Hirudoid (Chondroitin Polysulfate)

Hirudoid is a topical medication whose active ingredient is chondroitin polysulfate. It is supplied as a cream/gel (strength not specified) and is marketed in the European Union. The product is applied to the skin to address certain localized conditions. As a topical formulation, Hirudoid delivers the polysaccharide directly to the affected area, allowing for targeted action while minimizing systemic exposure and supporting the skin's natural repair processes.

Hirudoid is commonly used for topical management of superficial vascular and inflammatory skin conditions.

- Reduction of bruising (contusions) and associated swelling in the affected area. - Topical treatment of superficial thrombophlebitis, including minor varicose veins and related discomfort. - Alleviation of mild skin inflammation such as erythema, edema, and localized pain. - Adjunct therapy to minimize post‑procedural bruising and swelling after cosmetic or surgical procedures. - Supportive care for small hematomas, helping to accelerate resolution of discoloration.

Topical application of Hirudoid may be associated with local skin reactions, most of which are mild and reversible.

Common: - Mild redness at the application site. - Slight itching or tingling sensation. - Minor skin dryness or scaling. - Temporary burning feeling during application.

Serious: - Allergic contact dermatitis with widespread rash. - Severe swelling or hives indicating hypersensitivity. - Development of ulceration or necrosis at the site. - Persistent pain or infection requiring medical attention.

Before using Hirudoid, consider the following precautions to ensure safe and effective application.

- Avoid applying to broken, infected, or severely irritated skin. - Do not use on large surface areas or under occlusive dressings unless directed by a healthcare professional. - Discontinue use if signs of an allergic reaction develop. - Keep the product out of reach of children; accidental ingestion may cause gastrointestinal upset. - Consult a physician before use during pregnancy, breastfeeding, or when taking anticoagulant therapy. - Store at room temperature, protected from light and moisture.

Hirudoid may interact with other topical agents or systemic medications that affect blood clotting or skin integrity.

Avoid: - Concurrent use with other topical anticoagulants or heparin‑containing creams. - Application over areas treated with strong irritants such as retinoids or chemical peels.

Use with caution: - Systemic anticoagulants (e.g., warfarin, direct oral anticoagulants) as additive antithrombotic effect may increase bleeding risk. - Corticosteroid creams, which may alter skin absorption. - Herbal supplements with anticoagulant properties, such as ginkgo or garlic, when used systemically.